Dr. Mandar Bhalchandra Mulik

@kmkcp.edu.in

Assistant Professor
Principal K M Kundnani College of Pharmacy, Mumbai

EDUCATION

Ph. D. (Tech.) in Pharmacognosy from the Institute of Chemical Technology, Mumbai

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmacy, Pharmaceutical Science, Education, Drug Discovery
9

Scopus Publications

Scopus Publications

  • Exploration of steroidal alkaloids: Integrating pharmacognosy, chemoinformatics and artificial intelligence for application diversification
    Swati Patil, Mandar Mulik, Chetana Eknure, Yogeshwar Bachhav
    Steroids, 2026
  • Cubebin and Its Derivatives in Neurodegenerative Diseases and Their Antimicrobial Potential
    Swati Patil, Mandar Mulik
    Dietary Supplements and Nutraceuticals, 2025
  • Cannabis in the treatment of various cancers and its current global scenario
    Alternative Remedies and Natural Products for Cancer Therapy an Integrative Approach, 2023
  • Neuroprotective effect of Cubebin: A dibenzylbutyrolactone lignan on scopolamine-induced amnesia in mice
    Gauresh S. Somani, Mruniya S. Nahire, Aakash D. Parikh, Mandar B. Mulik, Priya J. Ghumatkar, Kirti S. Laddha, Sadhana Sathaye
    Indian Journal of Medical Research, 2017
    Background & objectives: Acetylcholinesterase (AChE) inhibitors represent a major class of drugs which provide symptomatic relief and improvement in cognitive function in Alzheimer's disease (AD). In this study, cubebin, a dibenzylbutyrolactone lignan, was isolated from Piper cubeba and investigated for its AChE inhibitory activity in an attempt to explore its potential for memory-enhancing activities in mice. Methods: Molecular docking of cubebin was carried out followed by in vitro AChE activity. Mice were treated with cubebin (25 & 50 mg/kg; i.p.), for three days and memory impairment was induced by scopolamine (3 mg/kg; i.p.). Memory function was evaluated by Morris water maze (MWM) test. Biochemical parameters of oxidative stress and cholinergic function were estimated in brain. Results: Molecular docking study revealed that cubebin was well bound within the binding site of the AChE enzyme showing interactions such as π-π stacking and hydrogen bonding with residues present therein. Cubebin inhibited AChE enzyme in an in vitro assay with IC50 value of 992 μM. Scopolamine administration caused a significant impairment of learning and memory in mice, as indicated by a marked decrease in MWM performance. Scopolamine administration also produced a significant enhancement of brain AChE activity and oxidative stress in mice brain. Pre-treatment of cubebin (25 and 50 mg/kg; i.p.) significantly prevented scopolamine-induced learning and memory deficits along with attenuation of scopolamine-induced rise in brain AChE activity and oxidative stress level. Interpretation & conclusions: Cubebin showed promising protective activity in scopolamine-induced spatial memory impairment in mice. This could be attributed to its brain AChE inhibition and antioxidant activity.
  • Isolation, characterization and quantification of bioactive dibenzylbutyrolactone lignan (-)-cubebin from fruits of piper cubeba L.f.
    Indian Journal of Natural Products and Resources, 2015
  • Quantification of β-amyrin in Bauhinia racemosa Lam. Flower buds using HPTLC
    Indian Drugs, 2015
  • Rapid simultaneous determination of marmelosin, umbelliferone and scopoletin from Aegle marmelos fruit by RP-HPLC
    P. B. Shinde, S. D. Katekhaye, M. B. Mulik, K. S. Laddha
    Journal of Food Science and Technology, 2014
  • Isolation and characterization of aristolochic acid - I from Aristolochia Indica Linn. Leaves
    Indian Drugs, 2013
  • Fate of β-asarone in Ayurvedic Sodhana process of Vacha
    ManasiS Gholkar, KirtiS Laddha, MandarB Mulik
    Journal of Ayurveda and Integrative Medicine, 2013